Shanghai Shenzhixin Biotechnology Co., Ltd. (referred to as "Shenzhixin Biotechnology") is an innovative enterprise that provides "systematic and high-quality cardiovascular disease research services". It builds a basic medical and clinical translation service system and carries out preclinical CRO services based on pharmacological evaluation, providing various mature cardiovascular disease model animals. Provide customized animal models, drug screening, pharmacological efficacy evaluation, safety evaluation, pathological analysis, and molecular biology testing services for research institutes, clinical departments, and pharmaceutical enterprises.